ECP 2023 Final Programme

Monday, 11 Sept One-Day Molecular Pathology Diagnostics Symposium 78 e Monday, 11 September 2023 MD-01 One-Day MD Symposium 08:30–09:30 Liffey Hall 2 Selected Abstracts Chairs: Sabine Merkelbach-Bruse, Germany Matthias Matter, Switzerland 001 08:30–08:45 External Quality Assessment (EQA) for PIK3CA testing in breast cancer: lessons learned and the need for continued quality improvement Victoria Williams, United Kingdom M. Cheetham, A. Maqsood, N. Wolstenholme, S. Patton 002 08:45–09:00 Health care providers’ knowledge, confidence and practice of molecular pathology testing for oncology, within an Irish university hospital setting Stephen Kearney, Ireland 003 09:00–09:15 Retrospective blind assessment of SOPHiA DDM™ Dx HRD solution for evaluation of olaparib maintenance treatment efficacy in ovarian cancer patients from the rand- omized, phase III PAOLA-1 trial Adrien Buisson, France M. Lamkhioued, P. Constantoulakis, K. Oikonomak, P. Harter, S. Pignata, A. Gonzalez-Martin, C. Schauer, K. Fujiwara, I. Vergote, N. Colombo, E. Pujade-Lauraine, I. Treilleux, P. Saintigny, I. Ray-Coquard 004 09:15–09:30 Optical genome mapping for comprehen- sive cytogenetic analysis of soft tissue and bone tumours Jef Baelen, Belgium I. Vanden Bempt, P. Schöffski, R. Sciot, B. Dewaele MD-02 One-Day MD Symposium 10:30–12:00 Liffey Hall 2 Update organ specific biomarker analysis Chairs: Carina Heydt, Germany Erik Jan Dubbink, The Netherlands 001 10:30–10:48 Update on molecular biomarkers in GI tumours Brendan Doyle, Ireland 002 10:48–11:06 Update on molecular biomarkers in thyroid cancer Udo Siebolts, Germany 003 11:06–11:24 Update on molecular biomarkers in lung cancer Paul Hofman, France 004 11:24–11:42 Update on molecular biomarkers in endometrial carcinomas Tjalling Bosse, The Netherlands 005 11:42–12:00 Update on molecular biomarkers in uropathology Nadine Gaisa, Germany